{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:55:37Z","timestamp":1776250537666,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04702-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:14:44Z","timestamp":1772882084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum and urinary mindin as a potential biomarker for diabetic retinopathy: a prospective cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-4985","authenticated-orcid":false,"given":"Ibrahim","family":"Dogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-2571","authenticated-orcid":false,"given":"Cagatay","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-2922","authenticated-orcid":false,"given":"Ahmet","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-4517","authenticated-orcid":false,"given":"Huseyin","family":"Kayadibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"4702_CR1","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12:1322\u20135.","journal-title":"J Diabetes Investig"},{"key":"4702_CR2","first-page":"1663","volume":"9","author":"C Caglar","year":"2016","unstructured":"Caglar C, Demir E, Kucukler K, Durmus M. A bibliometric analysis of academic publication on diabetic retinopathy disease trends during 1980\u20132014; a global and medical view. Int J Ophthalmol. 2016;9:1663\u20138.","journal-title":"Int J Ophthalmol"},{"key":"4702_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","volume":"23","author":"H Li","year":"2023","unstructured":"Li H, Liu X, Zhong H, et al. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol. 2023;23:372.","journal-title":"BMC Ophthalmol"},{"key":"4702_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s40135-016-0098-8","volume":"4","author":"E Atchison","year":"2016","unstructured":"Atchison E, Barkmeier A. The role of systemic risk factors in diabetic retinopathy. Curr Ophthalmol Rep. 2016;4:84\u20139.","journal-title":"Curr Ophthalmol Rep"},{"key":"4702_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2337\/diabetes.52.4.1031","volume":"52","author":"VM Dalla","year":"2003","unstructured":"Dalla VM, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52:1031\u20135.","journal-title":"Diabetes"},{"key":"4702_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/09286586.2010.498661","volume":"17","author":"AP Romero","year":"2010","unstructured":"Romero AP, Sagarra AR, Baget BM, Fernandez BJ, Marin IM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the north\u2013east of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17:251\u201365.","journal-title":"Ophthalmic Epidemiol"},{"key":"4702_CR7","doi-asserted-by":"publisher","first-page":"816400","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). 2022;13:816400.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4702_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4274\/tjo.galenos.2022.70375","volume":"53","author":"B Erdem","year":"2023","unstructured":"Erdem B, Kaya Y, K\u0131ran TR, Y\u0131lmaz S. An association between the intestinal permeability biomarker zonulin and the development of diabetic retinopathy in type 2 diabetes mellitus. Turk J Ophthalmol. 2023;53:91\u20136.","journal-title":"Turk J Ophthalmol"},{"key":"4702_CR9","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1182\/blood-2005-04-1658","volume":"106","author":"W Jia","year":"2005","unstructured":"Jia W, Li H, He YW. The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood. 2005;106:3854\u20139.","journal-title":"Blood"},{"key":"4702_CR10","doi-asserted-by":"publisher","first-page":"e0284789","DOI":"10.1371\/journal.pone.0284789","volume":"18","author":"ALMDS Martins","year":"2023","unstructured":"Martins ALMDS, Bernardes AB, Ferreira VA, et al. In situ assessment of mindin as a biomarker of podocyte lesions in diabetic nephropathy. PLoS ONE. 2023;18:e0284789.","journal-title":"PLoS ONE"},{"key":"4702_CR11","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/ndt\/gfq708","volume":"26","author":"M Murakoshi","year":"2011","unstructured":"Murakoshi M, Tanimoto M, Gohda T, Takagi SHM, Horikoshi S, Tomino Y. Mindin: a novel marker for podocyte injury in diabetic nephropathy. Nephrol Dial Transpl. 2011;26:2153\u201360.","journal-title":"Nephrol Dial Transpl"},{"key":"4702_CR12","first-page":"147","volume":"20","author":"IT \u015eambel","year":"2022","unstructured":"\u015eambel IT, Eren E, Bozyigit C, Sarand\u00f6l E. Serum mindin, nephrin and podocalyxin levels in patients with type 1 diabetes: are these new markers to detect the development of nephropathy? J Curr Pediatr. 2022;20:147\u201354.","journal-title":"J Curr Pediatr"},{"key":"4702_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786\u2013806.","journal-title":"Ophthalmology"},{"key":"4702_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1196\/annals.1288.006","volume":"1005","author":"K Haskins","year":"2003","unstructured":"Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci. 2003;1005:43\u201354.","journal-title":"Ann N Y Acad Sci"},{"key":"4702_CR15","doi-asserted-by":"publisher","first-page":"582060","DOI":"10.1155\/2015\/582060","volume":"2015","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Cancarini A, Dell\u2019Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060.","journal-title":"J Diabetes Res"},{"key":"4702_CR16","doi-asserted-by":"publisher","first-page":"e201023222418","DOI":"10.2174\/0115733998253672231011161400","volume":"20","author":"V Kour","year":"2024","unstructured":"Kour V, Swain J, Singh J, Singh H, Kour H. A Review on Diabetic Retinopathy. Curr Diabetes Rev. 2024;20:e201023222418.","journal-title":"Curr Diabetes Rev"},{"key":"4702_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11892-012-0258-7","volume":"12","author":"I Jialal","year":"2012","unstructured":"Jialal I, Kaur H. The role of Toll-like receptors in diabetes-induced inflammation: implications for vascular complications. Curr Diab Rep. 2012;12:172\u20139.","journal-title":"Curr Diab Rep"},{"key":"4702_CR18","doi-asserted-by":"publisher","first-page":"3940241","DOI":"10.1155\/2017\/3940241","volume":"2017","author":"JC Rivera","year":"2017","unstructured":"Rivera JC, Dabouz R, Noueihed B, Omri S, Tahiri H, Chemtob S. Ischemic Retinopathies: Oxidative Stress and Inflammation. Oxid Med Cell Longev. 2017;2017:3940241.","journal-title":"Oxid Med Cell Longev"},{"key":"4702_CR19","doi-asserted-by":"publisher","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799.","journal-title":"Redox Biol"},{"key":"4702_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni1021","volume":"5","author":"YW He","year":"2004","unstructured":"He YW, Li H, Zhang J, et al. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol. 2004;5:88\u201397.","journal-title":"Nat Immunol"},{"key":"4702_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3748\/wjg.v16.i9.1070","volume":"16","author":"B Guleng","year":"2010","unstructured":"Guleng B, Ya-Mei L, Lin Ren J. Mindin is upregulated during colitis and may activate NF-jB in a TLR-9 mediated manner. World J Gastroenterol. 2010;16:1070\u20135.","journal-title":"World J Gastroenterol"},{"key":"4702_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/nep.12507","volume":"20","author":"S Kahvecioglu","year":"2015","unstructured":"Kahvecioglu S, Guclu M, Ustundag Y, et al. Evaluation of serum spondin 2 levels in the different stages of type 2 diabetic nephropathy. Nephrol (Carlton). 2015;20:721\u20136.","journal-title":"Nephrol (Carlton)"},{"key":"4702_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1758-5996-3-9","volume":"3","author":"PK Rani","year":"2011","unstructured":"Rani PK, Raman R, Gupta A, Kulothungan V, Sharma T. Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Reti- nopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr. 2011;3:9.","journal-title":"Diabetol Metab Syndr"},{"key":"4702_CR24","doi-asserted-by":"publisher","first-page":"15987","DOI":"10.1038\/s41598-017-15993-3","volume":"7","author":"C Naudin","year":"2017","unstructured":"Naudin C, Smith B, Bond DR, Dun MD, Scott RJ, Ashman LK. Characterization of the early molecular changes in the glomeruli of Cd151 mice highlights induction of mindin and MMP-10. Sci Rep. 2017;7:15987.","journal-title":"Sci Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04702-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:07:33Z","timestamp":1776247653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04702-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4702"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04702-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Hitit University Medicine Faculty (approval number: 2016\/52; date: 06 January 2017). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript does not contain any individual person\u2019s data in any form (including individual images or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}